"The pharmacological and genetic modulation of astrocytic autophagy pathway can be considered for boosting the detoxifying ...
A research team has uncovered a new mechanism involving astrocytes for treating Alzheimer's disease (AD) and proposed a novel ...
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...
A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict ...
A research team led by Dr. Hoon Ryu from the Korea Institute of Science and Technology (KIST, President Sang-Rok Oh) Brain ...
In this episode we speak with bit.bio about astrocytes and how bit.bio's innovative technology is transforming research in ...
A research team led by Dr. Hoon Ryu from the Korea Institute of Science and Technology (KIST, President Sang-Rok Oh) Brain Disease Research Group, in collaboration with Director Justin C. Lee of the ...
Researchers have identified a novel therapeutic target for Alzheimer’s disease by focusing on astrocytes, non-neuronal brain cells involved in waste removal.
A drug called silibinin can block this protein and, when used with immunotherapy, may improve treatment for brain metastases.
CNIO researchers have discovered that cancer perverts certain brain cells, the astrocytes, and causes them to produce a ...
Discovery may offer new therapeutic target for development of new drugs against Alzheimer's and other neurodegenerative disorders.